A father of three is using being busy as a weapon in his fight against a rare autoimmune disease that has no cure.

A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving skin fibrosis in patients with early diffuse cutaneous systemic ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes.

Patients showed no difference in skin fibrosis whether they were given low-dose oral glucocorticoids or not. One patient in each treatment group had scleroderma renal crisis. Low doses of ...

A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...

[2] Patients with diffuse cutaneous scleroderma with skin thickening on the proximal extremities or the trunk are in highest danger of developing SRC, at 20% to 25%, and so should be followed ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Discover how vitamin D influences immune system development, particularly in T cell function, and its role in autoimmune ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...